Kshivets O. Synergetics and Survival of Lung Cancer Patients
Kshivets O. Lung Cancer Surgery: Synergetics and Prediction
-
Upload
oleg-kshivets -
Category
Health & Medicine
-
view
1.774 -
download
2
description
Transcript of Kshivets O. Lung Cancer Surgery: Synergetics and Prediction
SIGNIFICANT IMPACT OF PHASE TRANSITIONS SIGNIFICANT IMPACT OF PHASE TRANSITIONS AND CELL RATIO FACTORS FOR 5-YEAR SURVIVAL AND CELL RATIO FACTORS FOR 5-YEAR SURVIVAL
OF NON SMALLOF NON SMALLCELL LUNG CANCER PATIENTS AFTER SURGERYCELL LUNG CANCER PATIENTS AFTER SURGERY
Oleg Kshivets, MD, PhDOleg Kshivets, MD, PhDSurgery Department, Siauliai Public Hospital, LithuaniaSurgery Department, Siauliai Public Hospital, Lithuania
Abstract: N181SIGNIFICANT IMPACT OF PHASE TRANSITIONS AND CELL RATIO FACTORS FOR 5-YEAR SURVIVAL OF NON SMALL CELL LUNG CANCER PATIENTS AFTER RADICAL LOBECTOMIES AND PNEUMONECTOMIESOleg KshivetsSurgery Department, Siauliai Public Hospital, Siauliai, LithuaniaOBJECTIVE: The role of phase transitions (PT) in system “non-small cell lung cancer (LC)—human homeostasis” and cell ratio factors (CRF) (ratio between LC cell population: CC and blood cell subpopulations) for 5-year survival (5YS) after lobectomies/pneumonectomies was analyzed.METHODS: In trial (1985-2009) the data of consecutive 490 LC patients (LCP) after complete resections R0 (age=56.7±8 years; male - 439, female - 51; tumor diameter: D=4.5±2.1 cm; pneumonectomies - 206, lobectomies - 284, combined procedures with resection of pericardium, atrium, aorta, VCS, carina, diaphragm, esophagus, liver, chest wall, ribs, etc. - 130; squamous cell carcinoma - 308, adenocarcinoma - 147, large cell carcinoma - 35; T1 - 143, T2 - 217, T3 - 107, T4 - 23; N0 - 282, N1 - 115, N2 - 93; G1 - 114, G2 - 140, G3 - 236; early LC: LC till 2 cm in D with N0 - 58, invasive LC - 432) was reviewed. Variables selected for 5YS study were input levels of blood cell subpopulations, TNMG, D. Survival curves were estimated by Kaplan-Meier method. Differences in curves between groups were evaluated using a log-rank test. Neural networks computing, multivariate Cox regression, clustering, discriminant analysis, structural equation modeling, Monte Carlo and bootstrap simulation were used to determine any significant regularity. RESULTS: For total of 490 LCP overall life span (LS) was 1824±1304 days and real 5YS reached 62%, 10 years – 50.3%, 20 years – 45.3%. 304 LCP (LS=2597.3±1037 days) lived more than 5 years without LC progressing. 186 LCP (LS=559.8±383.1 days) died because of LC during first 5 years after surgery. 5YS of early LCP was significantly superior (100%) compared with invasive LCP (56.9%) (P=0.000 by log-rank test). 5YS of LCP with N0 was significantly better (78.4%) compared with LCP with N1-2 (39.9%) (P=0.000). Cox modeling displayed that 5YS significantly depended on: PT in terms of synergetics “early-invasive LC”, PT N0-N12, CRF (P=0.000-0.004). Neural networks computing, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT “early-invasive LC”, (rank=1), PT N0-N12 (2), erythrocytes/CC (3), healthy cells/CC (4), eosinophils/CC (5), lymphocytes/CC (6), monocytes/CC (7), thrombocytes/CC (8), segmented neutrophils/CC (9), leucocytes/CC (10), stab neutrophils/CC (11). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; urea under ROC curve=1.0). CONCLUSION: 5YS of LCP after radical procedures significantly depended on: 1) PT “early-invasive LC”; 2) PT N0-N12; 3) CRF; 4) LC characteristics.
Data:
Male………….…………..439Female………..……………51Age……..………56.7±8 yearsTumor Size…...…..4.5±2.1cm
Radical Procedures:Radical Procedures:
Pneumonectomy…………….…..206Bi/Lobectomy…........................…284In All…………………………......490
Combined & Extensive Radical Procedures with Resection of Pericardium, Atrium, Aorta, Vena Cava Superior, Vena Azygos, Carina, Trachea, Diaphragm, Chest Wall, Ribs, etc.…………………….130
Sistematic MediastinalSistematic MediastinalLymph Node-N2 Lymph Node-N2 Dissection…………..Dissection…………..490490
Staging:Staging:T1…..143 N0..…282 G1…..114T2…..217 N1…..115 G2…..140T3…..107 N2……93 G3…..236T4……23 Early LC...58 Invasive LC...432Squamous Cell Carcinoma…..……….308Adenocarcinoma………………………147Large Cell Carcinoma………………….35Central…………202 Peripherical…..288
Survival Rate of Lung Cancer Patients after Survival Rate of Lung Cancer Patients after Lobectomies and Pneumonectomies (R0) (n=490):Lobectomies and Pneumonectomies (R0) (n=490):
5-Year Survivors……………………...304 (62%) Losses from Lung Cancer…………….186 (38%)Life Span……………………..….1824±1304 days10-Year Survival………………………….50.3% 20-Year Survival………………………….45.3%5-Year Survival for Early LC……………100%5-Year Survival for Invasive LC…………56.9% 5-Year Survival for LC with N0…………78.4%5-Year Survival for LC with N1-2……….39.9%
Product-Limit (Kaplan-Maier) Analysis Results in Prediction of Lung Cancer Patients Survival after Lobectomies and Pneumonectomies (n=490):
Survival Function5-Year Survival=62%
10-Year Survival=50.3%20-Year Survival=45.3%
Complete Censored
-5 0 5 10 15 20 25
Years after Surgery
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
1.1
1.2
Cum
ulat
ive
Prop
ortio
n Su
rviv
ing
Survival of Early LCP was Significantly Better Compared to Invasive LCP:
Survival of LCP with N0 was Significantly Better Compared to LCP with N1-2:
Results of Multivariate Proportional Hazard Cox Regression Modeling in Prediction of LCP Survival after Lobectomies and
Pneumonectomies (n=490):
Global 2=131.51; Df=7; P=0.000
Results of Discriminant Function Analysis in Prediction of LCP survival after lobectomies and
pneumonectomies (n=490):
Wilks' Lambda=0.785; approx. F (4,485)=33.159 P=0.000Correct Classification Rate=72%
Wilks' - Lambda
Partial - Lambda
F-remove - (1,485) P Toler. 1-Toler. -
(R-Sqr.)
Phase Transition “Early LC---Invasive LC” 0.800861 0.980512 9.63957 0.002 0.905212 0.094787
Eosinophils/Cancer Cells 0.797277 0.984920 7.42555 0.007 0.837585 0.162415
Lymphocytes/Cancer Cells 0.792552 0.990791 4.50772 0.034 0.822803 0.177197
Phase Transition “N0---N12” 0.879453 0.892889 58.18034 0.000 0.947110 0.052890
Results of Multifactor Clustering of Cell RatioFactors in Prediction of Lung Results of Multifactor Clustering of Cell RatioFactors in Prediction of Lung Cancer Patients Survival after Lobectomies and Pneumonectomies (n=490):Cancer Patients Survival after Lobectomies and Pneumonectomies (n=490):
Correct Classification Rate=81%Correct Classification Rate=81%
Neural Networks in Prediction of Lung Cancer Patients Survival after Neural Networks in Prediction of Lung Cancer Patients Survival after Lobectomies and Pneumonectomies (n=490):Lobectomies and Pneumonectomies (n=490):
Losses 5-year survivors Baseline Errors=0.000;Total 186 304 Area under ROC curve=1.0;
Correct 186 304 Correct Classification Rate= 100%Wrong 0 0
Results of Neural Networks Computing in Prediction of 5-Year Survival of LCP after Lobectomies and Pneumonectomies (n=490):
Results of Bootstrap simulation in Prediction of Lung Cancer Patients Survival after Lobectomies
and Pneumonectomies (n=490):
Results of Kohonen Self-Organizing Neural Networks Computing in Prediction of Lung Cancer Patients Survival
after Lobectomies and Pneumonectomies (n=490):
Holling-Tenner Models of Alive Supersystem Holling-Tenner Models of Alive Supersystem “Lung Cancer-Cytotoxic Cell Population“Lung Cancer-Cytotoxic Cell Population”
Lung Cancer Dynamics:
SEPATH Networks in Prediction of Lung Cancer SEPATH Networks in Prediction of Lung Cancer Patients Survival after Lobectomies and Patients Survival after Lobectomies and
Pneumonectomies (n=490):Pneumonectomies (n=490):
Conclusions:Conclusions:5-year survival and life span of lung cancer patients after complete lobectomies and pneumonectomies significantly depended on: 1) phase transition “early---invasive lung cancer”; 2) phase transition “N0---N12”; 3) cell ratio factors (ratio between blood cell subpopulations and cancer cell population); 4) lung cancer characteristics.
Address: Oleg Kshivets, M.D., Ph.D.Thoracic Surgeon, Dep.of Surgery, Siauliai Public Hospital,Tilzes:42-16, Siauliai, LT78206, LithuaniaTel. (37041)416614 [email protected]//:myprofile.cos.com/Kshivets